Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
$340.38
1.850.55%
After Hours: 9:29 AM EDT
Comments
Loading...
HCA Healthcare Analyst Ratings and Price Targets | NYSE:HCA | Benzinga
HCA Healthcare Corp has a consensus price target of $567.61 based on the ratings of 38 analysts. The high is $1350 issued by HSBC on May 10, 2024<. The low is $100 issued by Deutsche Bank on August 5, 2024. The 3 most-recent analyst ratings were released by New Street Research, Goldman Sachs, and Deutsche Bank on August 6, 2024, August 5, 2024, and August 5, 2024, respectively. With an average price target of $118.33 between New Street Research, Goldman Sachs, and Deutsche Bank, there's an implied 0.21% upside for HCA Healthcare Corp from these most-recent analyst ratings.
Analyst Firms Making Recommendations1
RBC Capital
B of A Securities
Cantor Fitzgerald
Barclays
Keybanc
1calculated from analyst ratings
Analyst Ratings for HCA Healthcare
| Buy Now | Get Alert | |||||||
|---|---|---|---|---|---|---|---|---|
| 04/09/2025 | Buy Now | — | Guggenheim | Jason Cassorla51% | — | Initiates | → Neutral | Get Alert |
| 01/27/2025 | Buy Now | — | RBC Capital | Ben Hendrix60% | $405 → $384 | Maintains | Outperform | Get Alert |
| 01/27/2025 | Buy Now | — | B of A Securities | Kevin Fischbeck69% | $380 → $370 | Maintains | Buy | Get Alert |
| 01/27/2025 | Buy Now | — | Cantor Fitzgerald | Sarah James52% | $405 → $405 | Reiterates | Overweight → Overweight | Get Alert |
| 01/27/2025 | Buy Now | — | Barclays | Andrew Mok56% | $392 → $366 | Maintains | Overweight | Get Alert |
| 01/07/2025 | Buy Now | — | Keybanc | Tim Rezvan42% | $420 → $370 | Maintains | Overweight | Get Alert |
| 01/06/2025 | Buy Now | — | Truist Securities | David Macdonald68% | $430 → $390 | Maintains | Buy | Get Alert |
| 12/17/2024 | Buy Now | — | Morgan Stanley | Craig Hettenbach60% | $406 → $355 | Maintains | Equal-Weight | Get Alert |
| 12/17/2024 | Buy Now | — | JP Morgan | Benjamin Rossi12% | → $380 | Assumes | → Neutral | Get Alert |
| 11/25/2024 | Buy Now | — | Wells Fargo | Stephen Baxter59% | $400 → $320 | Downgrade | Equal-Weight → Underweight | Get Alert |
| 11/22/2024 | Buy Now | — | Raymond James | John Ransom76% | — | Downgrade | Outperform → Market Perform | Get Alert |
| 11/08/2024 | Buy Now | — | Barclays | Andrew Mok56% | $396 → $392 | Maintains | Overweight | Get Alert |
| 11/06/2024 | Buy Now | — | Wells Fargo | Stephen Baxter59% | $395 → $400 | Maintains | Equal-Weight | Get Alert |
| 10/28/2024 | Buy Now | — | TD Cowen | Gary Taylor63% | $450 → $440 | Maintains | Buy | Get Alert |
| 10/28/2024 | Buy Now | — | Keybanc | Matthew Gillmor64% | $475 → $420 | Maintains | Overweight | Get Alert |
| 10/28/2024 | Buy Now | — | Oppenheimer | Michael Wiederhorn63% | $390 → $400 | Maintains | Outperform | Get Alert |
| 10/22/2024 | Buy Now | — | Wells Fargo | Stephen Baxter59% | $365 → $395 | Maintains | Equal-Weight | Get Alert |
| 10/11/2024 | Buy Now | — | Keybanc | Matthew Gillmor64% | → $475 | Initiates | → Overweight | Get Alert |
| 10/04/2024 | Buy Now | — | Cantor Fitzgerald | Sarah James52% | $392 → $392 | Reiterates | Overweight → Overweight | Get Alert |
| 10/01/2024 | Buy Now | — | Cantor Fitzgerald | Sarah James52% | $392 → $392 | Reiterates | Overweight → Overweight | Get Alert |
| 09/03/2024 | Buy Now | — | Morgan Stanley | Craig Hettenbach60% | → $427 | Initiates | → Equal-Weight | Get Alert |
| 08/23/2024 | Buy Now | — | RBC Capital | Ben Hendrix60% | $378 → $405 | Maintains | Outperform | Get Alert |
| 08/20/2024 | Buy Now | — | Cantor Fitzgerald | Sarah James52% | $392 → $392 | Reiterates | Overweight → Overweight | Get Alert |
| 08/19/2024 | Buy Now | — | Cantor Fitzgerald | Sarah James52% | $392 → $392 | Reiterates | Overweight → Overweight | Get Alert |
| 08/19/2024 | Buy Now | — | Truist Securities | David Macdonald68% | $390 → $430 | Maintains | Buy | Get Alert |
| 08/14/2024 | Buy Now | — | UBS | Andrew Mok56% | $405 → $438 | Maintains | Buy | Get Alert |
| 07/30/2024 | Buy Now | — | Wells Fargo | Stephen Baxter59% | $315 → $365 | Maintains | Equal-Weight | Get Alert |
| 07/25/2024 | Buy Now | — | Cantor Fitzgerald | Sarah James52% | $335 → $392 | Maintains | Overweight | Get Alert |
| 07/24/2024 | Buy Now | — | Cantor Fitzgerald | Sarah James52% | $335 → $335 | Reiterates | Overweight → Overweight | Get Alert |
| 07/24/2024 | Buy Now | — | RBC Capital | Ben Hendrix60% | $329 → $378 | Maintains | Outperform | Get Alert |
| 07/24/2024 | Buy Now | — | Barclays | Andrew Mok56% | $376 → $396 | Maintains | Overweight | Get Alert |
| 07/24/2024 | Buy Now | — | Leerink Partners | — | $367 → $396 | Maintains | Outperform | Get Alert |
| 07/24/2024 | Buy Now | — | Oppenheimer | Michael Wiederhorn63% | $345 → $390 | Maintains | Outperform | Get Alert |
| 07/24/2024 | Buy Now | — | Truist Securities | David Macdonald68% | $375 → $390 | Maintains | Buy | Get Alert |
| 07/10/2024 | Buy Now | — | Barclays | Andrew Mok56% | $367 → $376 | Maintains | Overweight | Get Alert |
| 07/10/2024 | Buy Now | — | Cantor Fitzgerald | Sarah James52% | $335 → $335 | Reiterates | Overweight → Overweight | Get Alert |
| 07/09/2024 | Buy Now | — | Cantor Fitzgerald | Sarah James52% | $335 → $335 | Reiterates | Overweight → Overweight | Get Alert |
| 07/02/2024 | Buy Now | — | Cantor Fitzgerald | Sarah James52% | $335 → $335 | Reiterates | Overweight → Overweight | Get Alert |
| 06/28/2024 | Buy Now | — | Deutsche Bank | Pito Chickering68% | $359 → $375 | Maintains | Buy | Get Alert |
| 05/30/2024 | Buy Now | — | JP Morgan | Lisa Gill60% | $327 → $332 | Maintains | Neutral | Get Alert |
| 05/30/2024 | Buy Now | — | Baird | Michael Ha55% | → $396 | Initiates | → Outperform | Get Alert |
| 04/30/2024 | Buy Now | — | TD Cowen | Gary Taylor63% | $371 → $360 | Maintains | Buy | Get Alert |
| 04/29/2024 | Buy Now | — | Barclays | Andrew Mok56% | $356 → $367 | Maintains | Overweight | Get Alert |
| 04/29/2024 | Buy Now | — | RBC Capital | Ben Hendrix60% | $322 → $329 | Maintains | Outperform | Get Alert |
| 04/29/2024 | Buy Now | — | Oppenheimer | Michael Wiederhorn63% | $330 → $345 | Maintains | Outperform | Get Alert |
| 04/12/2024 | Buy Now | — | Deutsche Bank | Pito Chickering68% | $330 → $359 | Maintains | Buy | Get Alert |
| 04/10/2024 | Buy Now | — | Cantor Fitzgerald | Sarah James52% | $335 → $335 | Reiterates | Overweight → Overweight | Get Alert |
| 03/28/2024 | Buy Now | — | Wells Fargo | Stephen Baxter59% | $303 → $315 | Maintains | Equal-Weight | Get Alert |
| 03/06/2024 | Buy Now | — | Barclays | Andrew Mok56% | → $356 | Initiates | → Overweight | Get Alert |
| 03/05/2024 | Buy Now | — | Cantor Fitzgerald | Sarah James52% | $335 → $335 | Reiterates | Overweight → Overweight | Get Alert |
| 01/31/2024 | Buy Now | — | Raymond James | John Ransom76% | $300 → $330 | Maintains | Outperform | Get Alert |
| 01/31/2024 | Buy Now | — | RBC Capital | Ben Hendrix60% | $308 → $322 | Maintains | Outperform | Get Alert |
| 01/31/2024 | Buy Now | — | Truist Securities | David Macdonald68% | $320 → $345 | Maintains | Buy | Get Alert |
| 01/24/2024 | Buy Now | — | Raymond James | John Ransom76% | $280 → $300 | Maintains | Outperform | Get Alert |
| 01/19/2024 | Buy Now | — | Cantor Fitzgerald | Sarah James52% | $315 → $315 | Reiterates | Overweight → Overweight | Get Alert |
| 01/17/2024 | Buy Now | — | Oppenheimer | Michael Wiederhorn63% | → $315 | Reiterates | Outperform → Outperform | Get Alert |
| 01/04/2024 | Buy Now | — | Bernstein | Lance Wilkes67% | → $301 | Downgrade | Outperform → Market Perform | Get Alert |
| 12/11/2023 | Buy Now | — | Goldman Sachs | Jamie Perse62% | — | Downgrade | Buy → Neutral | Get Alert |
| 11/17/2023 | Buy Now | — | JP Morgan | Samik Chatterjee66% | $313 → $265 | Maintains | Neutral | Get Alert |
| 11/10/2023 | Buy Now | — | Stephens & Co. | Scott Fidel71% | → $280 | Reiterates | Overweight → Overweight | Get Alert |
| 10/30/2023 | Buy Now | — | Goldman Sachs | Jamie Perse62% | $329 → $281 | Maintains | Buy | Get Alert |
| 10/26/2023 | Buy Now | — | Wells Fargo | Stephen Baxter59% | $267 → $254 | Maintains | Equal-Weight | Get Alert |
| 10/25/2023 | Buy Now | — | Truist Securities | David Macdonald68% | $340 → $300 | Maintains | Buy | Get Alert |
| 10/25/2023 | Buy Now | — | Mizuho | Ann Hynes86% | $325 → $275 | Maintains | Buy | Get Alert |
| 10/25/2023 | Buy Now | — | RBC Capital | Ben Hendrix60% | $315 → $284 | Maintains | Outperform | Get Alert |
| 10/25/2023 | Buy Now | — | Stephens & Co. | Scott Fidel71% | $300 → $280 | Maintains | Overweight | Get Alert |
| 10/25/2023 | Buy Now | — | Citigroup | Jason Cassorla51% | $324 → $279 | Maintains | Buy | Get Alert |
| 10/25/2023 | Buy Now | — | Raymond James | John Ransom76% | $320 → $280 | Maintains | Outperform | Get Alert |
| 10/20/2023 | Buy Now | — | Wells Fargo | Stephen Baxter59% | $275 → $267 | Maintains | Equal-Weight | Get Alert |
| 09/14/2023 | Buy Now | — | Cantor Fitzgerald | Sarah James52% | → $315 | Reiterates | Overweight → Overweight | Get Alert |
| 09/13/2023 | Buy Now | — | RBC Capital | Ben Hendrix60% | → $315 | Reiterates | Outperform → Outperform | Get Alert |
| 07/28/2023 | Buy Now | — | Credit Suisse | A.J. Rice70% | $311 → $316 | Maintains | Outperform | Get Alert |
| 07/28/2023 | Buy Now | — | Oppenheimer | Michael Wiederhorn63% | $310 → $315 | Maintains | Outperform | Get Alert |
| 07/11/2023 | Buy Now | — | Mizuho | Ann Hynes86% | $305 → $325 | Maintains | Buy | Get Alert |
| 06/28/2023 | Buy Now | — | Barclays | Steve Valiquette55% | $275 → $300 | Maintains | Equal-Weight | Get Alert |
| 06/20/2023 | Buy Now | — | Truist Securities | David Macdonald68% | $325 → $340 | Maintains | Buy | Get Alert |
| 05/16/2023 | Buy Now | — | Mizuho | Ann Hynes86% | $298 → $305 | Maintains | Buy | Get Alert |
| 05/10/2023 | Buy Now | — | Argus Research | David Toung72% | $285 → $310 | Maintains | Buy | Get Alert |
| 04/25/2023 | Buy Now | — | Wells Fargo | Stephen Baxter59% | $243 → $275 | Maintains | Equal-Weight | Get Alert |
| 04/25/2023 | Buy Now | — | Bernstein | Lance Wilkes67% | $310 → $345 | Maintains | Outperform | Get Alert |
| 04/25/2023 | Buy Now | — | Barclays | Steve Valiquette55% | $256 → $275 | Maintains | Equal-Weight | Get Alert |
| 04/24/2023 | Buy Now | — | Truist Securities | David Macdonald68% | $310 → $325 | Maintains | Buy | Get Alert |
| 04/24/2023 | Buy Now | — | Jefferies | Brian Tanquilut44% | $325 → $350 | Maintains | Buy | Get Alert |
| 04/24/2023 | Buy Now | — | Deutsche Bank | Pito Chickering68% | $280 → $310 | Maintains | Buy | Get Alert |
| 04/24/2023 | Buy Now | — | Loop Capital | Joseph France66% | $285 → $320 | Maintains | Buy | Get Alert |
| 04/24/2023 | Buy Now | — | TD Cowen | Gary Taylor63% | $292 → $326 | Maintains | Outperform | Get Alert |
| 04/24/2023 | Buy Now | — | B of A Securities | Kevin Fischbeck69% | $294 → $323 | Maintains | Buy | Get Alert |
| 04/24/2023 | Buy Now | — | Raymond James | John Ransom76% | $300 → $320 | Maintains | Outperform | Get Alert |
| 04/24/2023 | Buy Now | — | RBC Capital | Ben Hendrix60% | $283 → $315 | Maintains | Outperform | Get Alert |
| 04/24/2023 | Buy Now | — | Credit Suisse | A.J. Rice70% | $282 → $311 | Maintains | Outperform | Get Alert |
| 04/24/2023 | Buy Now | — | Oppenheimer | Michael Wiederhorn63% | $270 → $310 | Maintains | Outperform | Get Alert |
| 04/24/2023 | Buy Now | — | Citigroup | Jason Cassorla51% | $293 → $324 | Maintains | Buy | Get Alert |
| 04/21/2023 | Buy Now | — | Stephens & Co. | Scott Fidel71% | → $283 | Reiterates | → Overweight | Get Alert |
| 04/21/2023 | Buy Now | — | Cantor Fitzgerald | Sarah James52% | → $304 | Initiates | → Overweight | Get Alert |
| 04/19/2023 | Buy Now | — | JP Morgan | Samik Chatterjee66% | $257 → $283 | Maintains | Neutral | Get Alert |
| 04/11/2023 | Buy Now | — | Mizuho | Ann Hynes86% | $279 → $298 | Maintains | Buy | Get Alert |
| 03/16/2023 | Buy Now | — | RBC Capital | Ben Hendrix60% | → $283 | Reiterates | → Outperform | Get Alert |
| 03/13/2023 | Buy Now | — | Stephens & Co. | Scott Fidel71% | → $283 | Reiterates | → Overweight | Get Alert |
| 02/23/2023 | Buy Now | — | JP Morgan | Lisa Gill60% | $235 → $257 | Maintains | Overweight | Get Alert |
| 02/22/2023 | Buy Now | — | Stephens & Co. | Scott Fidel71% | $275 → $283 | Maintains | Overweight | Get Alert |
FAQ
What is the target price for HCA Healthcare (HCA) stock?
The latest price target for HCA Healthcare (NYSE:HCA) was reported by Guggenheim on April 9, 2025. The analyst firm set a price target for $0.00 expecting HCA to fall to within 12 months (a possible -100.00% downside). 46 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for HCA Healthcare (HCA)?
The latest analyst rating for HCA Healthcare (NYSE:HCA) was provided by Guggenheim, and HCA Healthcare initiated their neutral rating.
When was the last upgrade for HCA Healthcare (HCA)?
There is no last upgrade for HCA Healthcare
When was the last downgrade for HCA Healthcare (HCA)?
The last downgrade for HCA Healthcare Inc happened on November 25, 2024 when Wells Fargo changed their price target from $400 to $320 for HCA Healthcare Inc.
When is the next analyst rating going to be posted or updated for HCA Healthcare (HCA)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of HCA Healthcare, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for HCA Healthcare was filed on April 9, 2025 so you should expect the next rating to be made available sometime around April 9, 2026.
Is the Analyst Rating HCA Healthcare (HCA) correct?
While ratings are subjective and will change, the latest HCA Healthcare (HCA) rating was a initiated with a price target of $0.00 to $0.00. The current price HCA Healthcare (HCA) is trading at is $332.94, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.